# Fulcrum Therapeutics, Inc.: filings

FULC · Nasdaq · CIK 1680581 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fulc.md) · [Financials](/companies/fulc/financials.md) · [Filings](/companies/fulc/filings.md) · [Insiders](/companies/fulc/insiders.md)

## Reports and events: 127 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 181, 8-K 84, 3 34, SC 13G/A 34, 10-Q 22, SC 13G 15, SCHEDULE 13G/A 13, 424B5 11, S-8 10, SCHEDULE 13G 8, 10-K 7, CORRESP 7, DEF 14A 7, DEFA14A 7, 144 6, EFFECT 6, UPLOAD 5, ARS 4, D 4, SEC STAFF LETTER 4, 10-K/A 3, 425 3, POS AM 2, S-1 2, S-1/A 2, S-3 2, S-4/A 2, 424B4 1, 4/A 1, 5 1, 8-A12B 1, CERT 1, D/A 1, DEFR14A 1, DRS 1, DRS/A 1, DRSLTR 1, FWP 1, POSASR 1, POS EX 1, PRE 14A 1, S-3ASR 1, S-3MEF 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-17 | 08:30 ET | [8-K](/filings/0001193125-26-353278.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-353278 |
| 2026-08-10 | 08:43 ET | [8-K](/filings/0001193125-26-341385.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-341385 |
| 2026-07-30 | 16:05 ET | [10-Q](/filings/0001193125-26-326098.md) | Quarterly report, period 2026-06-30 | 0001193125-26-326098 |
| 2026-06-25 | 16:32 ET | [8-K](/filings/0001193125-26-282873.md) | 5.07 Shareholder vote results | 0001193125-26-282873 |
| 2026-06-11 | 16:30 ET | [8-K](/filings/0001193125-26-267659.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-267659 |
| 2026-06-04 | 16:05 ET | [8-K](/filings/0001193125-26-257376.md) | 2.05 Exit or disposal costs; 8.01 Other events | 0001193125-26-257376 |
| 2026-06-01 | 16:05 ET | [8-K](/filings/0001193125-26-251394.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-251394 |
| 2026-04-30 | 16:06 ET | [DEF 14A](/filings/0001193125-26-197196.md) | Proxy statement, period 2026-06-24 | 0001193125-26-197196 |
| 2026-04-27 | 07:10 ET | [10-Q](/filings/0001193125-26-178814.md) | Quarterly report, period 2026-03-31 | 0001193125-26-178814 |
| 2026-04-27 | 07:05 ET | [8-K](/filings/0001193125-26-178806.md) | 1.02 Termination of a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-178806 |
| 2026-02-24 | 07:10 ET | [10-K](/filings/0001193125-26-065197.md) | Annual report, period 2025-12-31 | 0001193125-26-065197 |
| 2026-02-24 | 07:05 ET | [8-K](/filings/0001193125-26-065190.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-065190 |
| 2026-01-12 | 08:18 ET | [8-K](/filings/0001193125-26-009845.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009845 |
| 2025-12-11 | 21:36 ET | [8-K](/filings/0001193125-25-314728.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-314728 |
| 2025-12-08 | 06:32 ET | [8-K](/filings/0001193125-25-310509.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-310509 |
| 2025-10-29 | 07:10 ET | [10-Q](/filings/0001193125-25-254633.md) | Quarterly report, period 2025-09-30 | 0001193125-25-254633 |
| 2025-10-29 | 07:05 ET | [8-K](/filings/0001193125-25-254619.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-254619 |
| 2025-08-28 | 10:41 ET | [8-K](/filings/0001193125-25-190746.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-190746 |
| 2025-07-29 | 08:39 ET | [10-Q](/filings/0000950170-25-099407.md) | Quarterly report, period 2025-06-30 | 0000950170-25-099407 |
| 2025-07-29 | 08:34 ET | [8-K](/filings/0000950170-25-099404.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-099404 |
| 2025-06-27 | 16:14 ET | [8-K](/filings/0001193125-25-151276.md) | 5.07 Shareholder vote results | 0001193125-25-151276 |
| 2025-05-01 | 07:10 ET | [10-Q](/filings/0000950170-25-061442.md) | Quarterly report, period 2025-03-31 | 0000950170-25-061442 |
| 2025-05-01 | 07:05 ET | [8-K](/filings/0000950170-25-061439.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-061439 |
| 2025-04-30 | 16:00 ET | [DEF 14A](/filings/0000950170-25-061000.md) | Proxy statement, period 2025-04-25 | 0000950170-25-061000 |
| 2025-03-04 | 17:00 ET | [8-K](/filings/0000950170-25-032355.md) | 1.02 Termination of a material agreement | 0000950170-25-032355 |
| 2025-02-25 | 07:10 ET | [10-K](/filings/0000950170-25-026068.md) | Annual report, period 2024-12-31 | 0000950170-25-026068 |
| 2025-02-25 | 07:05 ET | [8-K](/filings/0000950170-25-026063.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-026063 |
| 2025-01-13 | 07:00 ET | [8-K](/filings/0001193125-25-004942.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-004942 |
| 2024-12-23 | 16:30 ET | [8-K](/filings/0001193125-24-284214.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-284214 |
| 2024-11-13 | 07:10 ET | [10-Q](/filings/0000950170-24-125931.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125931 |
| 2024-11-13 | 07:05 ET | [8-K](/filings/0000950170-24-125927.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125927 |
| 2024-11-12 | 17:21 ET | [8-K](/filings/0001193125-24-256101.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-256101 |
| 2024-09-24 | 16:05 ET | [8-K](/filings/0000950170-24-109069.md) | 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0000950170-24-109069 |
| 2024-09-12 | 12:43 ET | [8-K](/filings/0001193125-24-217822.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-217822 |
| 2024-08-22 | 16:02 ET | [8-K](/filings/0001193125-24-205347.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-24-205347 |
| 2024-07-31 | 07:15 ET | [10-Q](/filings/0000950170-24-088238.md) | Quarterly report, period 2024-06-30 | 0000950170-24-088238 |
| 2024-07-31 | 07:10 ET | [8-K](/filings/0000950170-24-088236.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-088236 |
| 2024-06-17 | 16:37 ET | [8-K](/filings/0001193125-24-162653.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-24-162653 |
| 2024-05-13 | 07:15 ET | [10-Q](/filings/0000950170-24-058193.md) | Quarterly report, period 2024-03-31 | 0000950170-24-058193 |
| 2024-05-13 | 07:05 ET | [8-K](/filings/0000950170-24-058187.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-058187 |
| 2024-04-19 | 16:05 ET | [DEF 14A](/filings/0001193125-24-102863.md) | Proxy statement, period 2024-06-17 | 0001193125-24-102863 |
| 2024-02-27 | 16:01 ET | [10-K](/filings/0000950170-24-021074.md) | Annual report, period 2023-12-31 | 0000950170-24-021074 |
| 2024-02-27 | 07:01 ET | [8-K](/filings/0000950170-24-020615.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-020615 |
| 2023-11-07 | 07:05 ET | [10-Q](/filings/0000950170-23-059755.md) | Quarterly report, period 2023-09-30 | 0000950170-23-059755 |
| 2023-11-07 | 07:02 ET | [8-K](/filings/0000950170-23-059753.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-059753 |
| 2023-10-02 | 16:01 ET | [8-K](/filings/0001193125-23-249011.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-249011 |
| 2023-08-22 | 07:01 ET | [8-K](/filings/0001193125-23-217439.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-217439 |
| 2023-08-03 | 07:11 ET | [10-Q](/filings/0000950170-23-037579.md) | Quarterly report, period 2023-06-30 | 0000950170-23-037579 |
| 2023-08-03 | 07:05 ET | [8-K](/filings/0000950170-23-037574.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-037574 |
| 2023-07-10 | 17:06 ET | [8-K](/filings/0001193125-23-184748.md) | 1.01 Entry into a material agreement | 0001193125-23-184748 |

Page 1 of 3. [Older](/companies/fulc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:11 ET. No prices; not investment advice.